flucytosine - Profile
✉ Email this page to a colleague
What are the generic sources for flucytosine and what is the scope of patent protection?
Flucytosine
is the generic ingredient in two branded drugs marketed by Bausch, Aurobindo Pharma Ltd, Hikma, Laurus, Novel Labs Inc, Sigmapharm Labs Llc, and Strides Pharma, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.Summary for flucytosine
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 7 |
| NDAs: | 8 |
US Patents and Regulatory Information for flucytosine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | ANCOBON | flucytosine | CAPSULE;ORAL | 017001-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Bausch | ANCOBON | flucytosine | CAPSULE;ORAL | 017001-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Aurobindo Pharma Ltd | FLUCYTOSINE | flucytosine | CAPSULE;ORAL | 213665-001 | May 1, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Aurobindo Pharma Ltd | FLUCYTOSINE | flucytosine | CAPSULE;ORAL | 213665-002 | May 1, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hikma | FLUCYTOSINE | flucytosine | CAPSULE;ORAL | 206550-001 | Oct 17, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | FLUCYTOSINE | flucytosine | CAPSULE;ORAL | 206550-002 | Oct 17, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
